Log in to save to my catalogue

Cost-effectiveness of newborn screening for severe combined immunodeficiency

Cost-effectiveness of newborn screening for severe combined immunodeficiency

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2186143514

Cost-effectiveness of newborn screening for severe combined immunodeficiency

About this item

Full title

Cost-effectiveness of newborn screening for severe combined immunodeficiency

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of pediatrics, 2019-05, Vol.178 (5), p.721-729

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Severe combined immunodeficiency (SCID) is a condition that often results in severe infections and death at young age. Early detection shortly after birth, followed by treatment before infections occur, largely increases the chances of survival. As the incidence of SCID is low, assessing cost-effectiveness of adding screening for SCID to the newbor...

Alternative Titles

Full title

Cost-effectiveness of newborn screening for severe combined immunodeficiency

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2186143514

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2186143514

Other Identifiers

ISSN

0340-6199

E-ISSN

1432-1076

DOI

10.1007/s00431-019-03346-3

How to access this item